Evidence map›Paper›PMID 36360742›Full record

ArticleInternational journal of environmental research and public health2022

Stroke and TIA Survivors' Perceptions of the COVID-19 Vaccine and Influences on Its Uptake: Cross Sectional Survey.

Grace M Turner, Neil Heron, Jennifer Crow, Eirini Kontou, Sally Hughes

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Grace M TurnerInstitute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK.ORCID 0000-0002-9783-9413
Neil HeronCentre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queens University Belfast, Belfast BT12 6BA, UK.ORCID 0000-0002-4123-9806
Jennifer CrowImperial College Healthcare NHS Trust, London W6 8RF, UK.ORCID 0000-0003-4692-1799
Eirini KontouInstitute of Mental Health, Nottinghamshire Healthcare NHS Foundation Trust, Nottingham NG3 6AA, UK.ORCID 0000-0001-5837-9891
Sally HughesInstitute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK.
University of Birmingham · GBImperial College Healthcare NHS Trust · GBQueen's University Belfast · GBUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeople who have experienced a stroke or transient ischaemic attack (TIA) have greater risks of complications from COVID-19. Therefore, vaccine uptake in this vulnerable population is important. To prevent vaccine hesitancy and maximise compliance, we need to better understand individuals' views on the vaccine.

objectivesWe aimed to explore perspectives of the COVID-19 vaccine and influences on its uptake from people who have experienced a stroke or TIA.

methodA cross-sectional, electronic survey comprising multiple choice and free text questions. Convenience sampling was used to recruit people who have experienced a stroke/TIA in the UK/Ireland.

resultsThe survey was completed by 377 stroke/TIA survivors. 87% (328/377) had either received the first vaccine dose or were booked to have it. The vaccine was declined by 2% (7/377) and 3% (11/377) had been offered the vaccine but not yet taken it up. 8% (30/377) had not been offered the vaccine despite being eligible. Some people expressed concerns around the safety of the vaccine (particularly risk of blood clots and stroke) and some were hesitant to have the second vaccine. Societal and personal benefits were motivations for vaccine uptake. There was uncertainty and lack of information about risk of COVID-19 related complications specifically for people who have experienced a stroke or TIA.

conclusionDespite high uptake of the first vaccine, some people with stroke and TIA have legitimate concerns and information needs that should be addressed. Our findings can be used to identify targets for behaviour change to improve vaccine uptake specific to stroke/TIA patients.

Indexed as

COVID-19Ischemic Attack, TransientStrokeCOVID-19 VaccinesCross-Sectional StudiesHumansSurvivorsCOVID-19 VaccinesCOVID-19strokesurveytransient ischaemic attackvaccinevaccine hesitancy

Identifiers

PMID36360742
PMCPMC9658254
OpenAlexW4307550426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.